Part 7/8:
The discussion also covered the potential of GLP-1 drugs, which are primarily used to treat obesity and diabetes, showing promise in addressing issues related to drug and alcohol use. Preliminary research involving animal models indicates that these drugs may prevent compulsive drug-taking behaviors and reduce cravings. Promising anecdotal evidence from those using these medications suggests a decrease in the desire for alcohol and other addictive substances.
Ongoing randomized clinical trials will further evaluate the efficacy of GLP-1 drugs for treating addiction, with hopes that these findings could lead to FDA approval in the future.